Please login to the form below

Not currently logged in

Excellence in Patient Education and Support

Sponsored by

Back to Results

Highly Commended

Assure patient support programme (Asacol®)

by Actavis and Allergan UK
with support from Atlantis Healthcare

Summary of work

Poor adherence is an issue in ulcerative colitis (UC) leading to patients having an increased number of flare-ups, which in turn escalates healthcare costs. Non-adherence considerably impacts on patients’ quality-of-life and causes substantial psychological burden.

Designed for UC patients prescribed Asacol® (mesalazine) tablets, the Assure patient support programme aims to enhance patient overall well-being by addressing beliefs and concerns that are key to improving adherence. Speaking about Assure, Dr Matthew Johnson, a gastroenterologist at Luton and Dunstable Hospital remarked “it’s enlightening to see such an innovative support programme aimed at tackling some of the fundamental issues in UC including non-adherence”.

The key measures of project success were enrolment and increase in persistence to treatment. A wider range of measures were also tracked within a sample of patients to evaluate the perceived value of the service and to determine the impact on patient outcomes. 

Judges' comments

Using a multi-channel, multimedia approach the team developed beautiful and engaging content packed full of tips and information. It is both effective and connected, which was no mean feat. The team achieved impressive outcomes, showcased through strong measurement, from a base of systematic review.


One Heart support programme - by AstraZeneca UK
with support from Atlantis Healthcare

Highly commended

Assure patient support programme (Asacol®) - by Actavis and Allergan UK
with support from Atlantis Healthcare

Highly commended


Don’t Turn Your Back On It (Global) - by AbbVie
with support from Biosector 2

Positive Conversations - by Gilead
with support from inVentiv Medical Communications

SymTrac – A master class in patient-centred programme design - by Novartis
with support from Aurora

Rethinking Hepatitis - by World Hepatitis Alliance
with support from Ketchum

Key dates

Entry deadline 26 August 2021
Extended entry deadline 2 September 2021*
*additional fee applies
Judging Day 1 October 2021
Company of the Year Interviews 22 October 2021
PMEA Event 24 November 2021